Peroxisome proliferator-activated receptor-γ2 (PPARγ) polymorphism Pro12Ala and diabetic nephropathy in Type 1 diabetic patients in the FinnDiane Study

被引：0
作者：
Forsblom, CM
Fröjdö, S
Parkkonen, M
Pettersson-Fernholm, K
Fagerudd, J
Groop, PH
机构：
[1] Univ Helsinki, Cent Hosp, Dept Med, Div Nephrol, FIN-00014 Helsinki, Finland
[2] Folkhalsan Res Ctr, Helsinki, Finland
来源：
DIABETOLOGIA | 2003年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
968
引用
收藏
页码：A334 / A335
页数：2
相关论文
共 50 条
  • [41] Relationship between peroxisome proliferator-activated receptor-γ (ppar-γ) pro12ala polymorphism and insulin sensitivity depends on fish consumption in adolescents
    Copin, N.
    Platat, C.
    Bedel, J. F.
    Oujaa, M.
    Lacorte, J. M.
    Clement, K.
    Simon, C.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S188 - S188
  • [42] Ala/Ala Genotype of Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor-γ2 Gene Is Associated with Obesity and Insulin Resistance in Asian Indians
    Bhatt, Surya Prakash
    Misra, Anoop
    Sharma, Mukti
    Luthra, Kalpana
    Guleria, Randeep
    Pandey, Ravindra Mohan
    Vikram, Naval K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (09) : 828 - 834
  • [43] Peroxisome proliferator-activated receptor-γPro12Ala polymorphism and the association with blood pressure in type 2 diabetes:: Skaraborg Hypertension and Diabetes Project
    Östgren, CJ
    Lindblad, U
    Melander, O
    Melander, A
    Groop, L
    Råstam, L
    JOURNAL OF HYPERTENSION, 2003, 21 (09) : 1657 - 1662
  • [44] Pro12Ala mutation in the peroxisome proliferator-activated receptor γ2 (PPARγ2) and severe obesity: a case–control study
    O Vaccaro
    FP Mancini
    G Ruffa
    L Sabatino
    V Colantuoni
    G Riccardi
    International Journal of Obesity, 2000, 24 : 1195 - 1199
  • [45] Increased insulin clearance in peroxisome proliferator-activated receptor γ2 Pro12Ala
    Tschritter, O
    Fritsche, A
    Stefan, N
    Haap, M
    Thamer, C
    Bachmann, O
    Dahl, D
    Maerker, E
    Teigeler, A
    Machicao, F
    Häring, H
    Stumvoll, M
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (06): : 778 - 783
  • [46] Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 gene on rosiglitazone response in type 2 diabetes
    Kang, ES
    Park, SY
    Kim, HJ
    Kim, CS
    Ahn, CW
    Cha, BS
    Lim, SK
    Nam, CM
    Lee, HC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (02) : 202 - 208
  • [47] Effect of the peroxisome proliferator-activated receptor-γ2 Pro12Ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds
    Hasstedt, SJ
    Ren, QF
    Teng, K
    Elbein, SC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) : 536 - 541
  • [48] The protective effect of the Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ (PPARγ) isoform 2 in progression to diabetes in a Pakistani cohort
    Khushbakht
    Sarwar, Sumbal
    Shabana
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2018, 38 (02) : 238 - 242
  • [49] The protective effect of the Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ (PPARγ) isoform 2 in progression to diabetes in a Pakistani cohort
    Sumbal Khushbakht
    International Journal of Diabetes in Developing Countries, 2018, 38 : 238 - 242
  • [50] Contribution of the Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma 2 gene in relation to obesity
    Zahri, Mohd Khairi
    Emilia, Apidi
    Rawi, Rohayu Izanwati Mohd
    Taib, Wan Rohani Wan
    Sani, Aliya Irshad
    Baig, Atif Amin
    META GENE, 2016, 10 : 39 - 44
12345